GHK-Cu is supplied by UKPeptides as copper tripeptide-1, a laboratory research material presented in a 50 mg lyophilised vial. Researchers refer to it by the designation copper tripeptide-1 when documenting laboratory work. UKPeptides reserves the copper tripeptide profile for controlled bench investigation alone.
Laboratory teams study GHK-Cu across collagen-pathway models, matrix signalling and dermal-fibroblast assays. Each of these named research models frames how the peptide is examined in controlled laboratory settings. The copper tripeptide is furnished for the research bench alone, outside any human, animal, medical, dietary or cosmetic setting.
A clear compound profile helps laboratories understand identity, specification and documentation before sourcing. UKPeptides pairs GHK-Cu with reverse-phase High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) verification. That verification connects each 50 mg vial to a batch-specific Certificate of Analysis (COA).
What Is GHK-Cu As A Research Compound?
GHK-Cu is described as copper tripeptide-1, a copper-bound tripeptide handled as a laboratory research material. UKPeptides catalogues it as a defined identity rather than a formulated product. The designation copper tripeptide-1 gives laboratories a consistent label for records and referencing.
Reference data for the compound is available through PubChem and PubMed, which support identity confirmation during laboratory planning. Researchers use these databases to align catalogue material with published chemical records. UKPeptides restricts every description to the named research models and the verification methods applied to each lot. The compound is not framed as a medicine, supplement, food or cosmetic in any catalogue text.
Handling GHK-Cu as a defined research material keeps laboratory documentation consistent from order to storage. The 50 mg lyophilised vial gives a fixed quantity that laboratories can log against their own records. UKPeptides treats copper tripeptide-1 as a single catalogue identity rather than a variable preparation.
- Catalogued as copper tripeptide-1, a defined laboratory research material
- Supplied as a fixed 50 mg lyophilised vial identity
- Held as a single catalogue entry, not a formulated preparation
Which Research Models Study GHK-Cu?
Laboratories examine GHK-Cu within collagen-pathway models, where copper tripeptide-1 is studied in controlled assay conditions. Matrix signalling work provides another named context for laboratory investigation. Dermal-fibroblast assays complete the set of research models tied to this compound.
UKPeptides confines its language to these three research models and does not extend claims beyond them. To source verified material, laboratories can buy ghk-cu directly from the UKPeptides catalogue with full documentation.
- Collagen-pathway models frame the first controlled research context
- Matrix signalling provides the second named laboratory model
- Dermal-fibroblast assays complete the three research models studied
How Does UKPeptides Verify Each 50 Mg Vial?
Every GHK-Cu lot is analysed by reverse-phase HPLC, which separates and measures the material against a purity threshold. LC-MS then confirms the identity of copper tripeptide-1 by mass. Together these methods support verification to 99.0% purity for each lot.
UKPeptides ties every 50 mg vial to a batch-specific COA linked to the lot number. That document records the verification outcome for the specific batch supplied. Laboratories can match the vial in hand to its COA for traceable record-keeping. The lot number on the COA links the physical vial to its HPLC and LC-MS results.
This documentation chain lets a laboratory trace copper tripeptide-1 from receipt through to its verification record. HPLC handles the purity measurement while LC-MS confirms molecular identity for the same lot. Keeping both methods on record supports consistent laboratory sourcing across repeat orders.
| Attribute | Specification |
|---|---|
| Identity | Copper tripeptide-1 (GHK-Cu) |
| Class | Laboratory research material |
| Purity | Verified to 99.0% |
| Verification | Reverse-phase HPLC and LC-MS |
| Vial | 50 mg lyophilised |
| Storage | Sealed at -20C, reconstituted 2-8C |
How Does GHK-Cu Sit Within The Catalogue?
UKPeptides lists related catalogue items alongside GHK-Cu for laboratories comparing options. The GHK-Cu Blend is a copper tripeptide complex blend held as a separate catalogue entry. Pal-GHK is catalogued as palmitoyl tripeptide-1, and Glow is a peptide blend.
These related items sit next to GHK-Cu as distinct catalogue choices rather than substitutes. The GHK-Cu profile centres on the single copper tripeptide-1 identity in the 50 mg lyophilised vial. Laboratories select the entry that matches their research records and documentation needs.
- GHK-Cu Blend is a copper tripeptide complex, held separately
- Pal-GHK is catalogued as palmitoyl tripeptide-1, a distinct entry
- Glow is a peptide blend listed alongside as another option
How Is GHK-Cu Handled And Dispatched?
GHK-Cu is supplied lyophilised and stored sealed at -20C, with reconstituted material kept at 2-8C. These conditions preserve the copper tripeptide-1 material through handling and storage. UKPeptides applies cold-chain handling to protect the 50 mg vial in transit.
Orders confirmed ahead of the 3pm GMT cut-off leave UKPeptides the same working day within the UK. Shipping is discreet, tracked and insured, with EU and international delivery available. Ordering is restricted to those aged 21 and over.
The verified specification for the 50 mg GHK-Cu research vial appears at https://ukpeptides.com/catalog/ghk-cu
Frequently Asked Questions
What Is GHK-Cu Supplied As?
UKPeptides supplies GHK-Cu as copper tripeptide-1, a laboratory research material presented in a single 50 mg lyophilised vial with a matching lot number. The copper tripeptide is furnished for the research bench alone, outside any human, animal, medical, dietary or cosmetic setting. Each vial carries its own batch-specific Certificate of Analysis so records stay traceable from receipt through to storage.
How Is Purity Confirmed For GHK-Cu?
Every copper tripeptide-1 lot is analysed by reverse-phase HPLC, which separates the material and measures it to 99.0% purity. LC-MS then confirms molecular identity by mass for the same lot. UKPeptides ties both results to a batch-specific COA carrying the lot number, so laboratories can match the supplied 50 mg vial to its Certificate of Analysis for traceable record-keeping across repeat orders.
Which Research Models Reference GHK-Cu?
GHK-Cu is examined within three named laboratory contexts: collagen-pathway models, matrix signalling and dermal-fibroblast assays. UKPeptides describes copper tripeptide-1 only inside these research models and does not extend any wording past them. Reference records held in PubChem and PubMed help laboratories confirm identity during planning, so catalogue material can be aligned with published chemical data before sourcing.
How Is GHK-Cu Stored And Shipped?
GHK-Cu is kept sealed at -20C, with reconstituted copper tripeptide-1 held at 2-8C, and cold-chain handling protects the 50 mg vial in transit. Orders confirmed ahead of the 3pm GMT cut-off leave the UK the same working day. Shipping is discreet, tracked and insured, with EU and international options available for buyers aged 21 and over.
